Does the media refer more to IDXX or NVST?

In the previous week, IDEXX Laboratories and IDEXX Laboratories both had 5 articles in the media. Envista's average media sentiment score of 0.47 beat IDEXX Laboratories' score of 0.27 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ISRG or IDXX?

In the previous week, Intuitive Surgical had 19 more articles in the media than IDEXX Laboratories. MarketBeat recorded 24 mentions for Intuitive Surgical and 5 mentions for IDEXX Laboratories. Intuitive Surgical's average media sentiment score of 0.50 beat IDEXX Laboratories' score of 0.27 indicating that Intuitive Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 5 Very Positive mention(s) 6 Positive mention(s) 9 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Positive IDEXX Laboratories 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor IDXX or MDT?

In the previous week, Medtronic had 49 more articles in the media than IDEXX Laboratories. MarketBeat recorded 54 mentions for Medtronic and 5 mentions for IDEXX Laboratories. Medtronic's average media sentiment score of 0.45 beat IDEXX Laboratories' score of 0.27 indicating that Medtronic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Medtronic 20 Very Positive mention(s) 12 Positive mention(s) 14 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to SYK or IDXX?

In the previous week, Stryker had 5 more articles in the media than IDEXX Laboratories. MarketBeat recorded 10 mentions for Stryker and 5 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 0.27 beat Stryker's score of 0.18 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stryker 0 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral IDEXX Laboratories 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor IDXX or BSX?

In the previous week, Boston Scientific had 4 more articles in the media than IDEXX Laboratories. MarketBeat recorded 9 mentions for Boston Scientific and 5 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 0.27 beat Boston Scientific's score of 0.08 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Boston Scientific 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

IDEXX Laboratories (IDXX) Competitors

$527.07 +8.68 (+1.67%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$531.18 +4.11 (+0.78%)

As of 04:04 AM Eastern

Compare

IDXX vs. NVST, ISRG, MDT, SYK, and BSX

Should you buy IDEXX Laboratories stock or one of its competitors? IDEXX Laboratories's main competitors and comparable companies include Envista (NVST), Intuitive Surgical (ISRG), Medtronic (MDT), Stryker (SYK), and Boston Scientific (BSX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment & supplies" industry.

How does IDEXX Laboratories compare to Envista?

IDEXX Laboratories (NASDAQ:IDXX) and Envista (NYSE:NVST) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

IDEXX Laboratories has higher revenue and earnings than Envista. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	9.65	$1.06B	$14.22	37.07
Envista	$2.72B	1.38	$47M	$0.58	40.32

IDEXX Laboratories currently has a consensus target price of $747.00, suggesting a potential upside of 41.73%. Envista has a consensus target price of $29.79, suggesting a potential upside of 27.37%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, analysts clearly believe IDEXX Laboratories is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envista	0 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.53

In the previous week, IDEXX Laboratories and IDEXX Laboratories both had 5 articles in the media. Envista's average media sentiment score of 0.47 beat IDEXX Laboratories' score of 0.27 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envista	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

IDEXX Laboratories has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market. Comparatively, Envista has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market.

IDEXX Laboratories has a net margin of 25.03% compared to Envista's net margin of 3.33%. IDEXX Laboratories' return on equity of 71.96% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Envista	3.33%	7.88%	4.33%

87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

IDEXX Laboratories beats Envista on 11 of the 16 factors compared between the two stocks.

How does IDEXX Laboratories compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

Intuitive Surgical has a net margin of 28.45% compared to IDEXX Laboratories' net margin of 25.03%. IDEXX Laboratories' return on equity of 71.96% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.45%	16.91%	14.83%
IDEXX Laboratories	25.03%	71.96%	33.60%

Intuitive Surgical presently has a consensus target price of $508.68, indicating a potential upside of 25.14%. IDEXX Laboratories has a consensus target price of $747.00, indicating a potential upside of 41.73%. Given IDEXX Laboratories' higher possible upside, analysts plainly believe IDEXX Laboratories is more favorable than Intuitive Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.68
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by insiders. Comparatively, 0.8% of IDEXX Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Intuitive Surgical has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market.

Intuitive Surgical has higher revenue and earnings than IDEXX Laboratories. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	14.27	$2.86B	$8.73	46.56
IDEXX Laboratories	$4.30B	9.65	$1.06B	$14.22	37.07

In the previous week, Intuitive Surgical had 19 more articles in the media than IDEXX Laboratories. MarketBeat recorded 24 mentions for Intuitive Surgical and 5 mentions for IDEXX Laboratories. Intuitive Surgical's average media sentiment score of 0.50 beat IDEXX Laboratories' score of 0.27 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	5 Very Positive mention(s)	6 Positive mention(s)	9 Neutral mention(s)	3 Negative mention(s)	1 Very Negative mention(s)	Positive
IDEXX Laboratories	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Intuitive Surgical beats IDEXX Laboratories on 9 of the 16 factors compared between the two stocks.

How does IDEXX Laboratories compare to Medtronic?

IDEXX Laboratories (NASDAQ:IDXX) and Medtronic (NYSE:MDT) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

IDEXX Laboratories has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market. Comparatively, Medtronic has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market.

In the previous week, Medtronic had 49 more articles in the media than IDEXX Laboratories. MarketBeat recorded 54 mentions for Medtronic and 5 mentions for IDEXX Laboratories. Medtronic's average media sentiment score of 0.45 beat IDEXX Laboratories' score of 0.27 indicating that Medtronic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Medtronic	20 Very Positive mention(s)	12 Positive mention(s)	14 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Neutral

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by insiders. Comparatively, 0.3% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

IDEXX Laboratories has a net margin of 25.03% compared to Medtronic's net margin of 13.93%. IDEXX Laboratories' return on equity of 71.96% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Medtronic	13.93%	14.78%	7.97%

IDEXX Laboratories presently has a consensus price target of $747.00, indicating a potential upside of 41.73%. Medtronic has a consensus price target of $103.92, indicating a potential upside of 18.07%. Given IDEXX Laboratories' higher probable upside, analysts plainly believe IDEXX Laboratories is more favorable than Medtronic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Medtronic	0 Sell rating(s)	9 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.68

Medtronic has higher revenue and earnings than IDEXX Laboratories. Medtronic is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	9.65	$1.06B	$14.22	37.07
Medtronic	$36.36B	3.10	$4.80B	$4.06	21.68

Summary

IDEXX Laboratories beats Medtronic on 10 of the 16 factors compared between the two stocks.

How does IDEXX Laboratories compare to Stryker?

Stryker (NYSE:SYK) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

In the previous week, Stryker had 5 more articles in the media than IDEXX Laboratories. MarketBeat recorded 10 mentions for Stryker and 5 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 0.27 beat Stryker's score of 0.18 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stryker	0 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
IDEXX Laboratories	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Stryker currently has a consensus target price of $372.64, indicating a potential upside of 30.51%. IDEXX Laboratories has a consensus target price of $747.00, indicating a potential upside of 41.73%. Given IDEXX Laboratories' higher probable upside, analysts clearly believe IDEXX Laboratories is more favorable than Stryker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.79
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Stryker has higher revenue and earnings than IDEXX Laboratories. Stryker is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$25.12B	4.36	$3.25B	$9.65	29.59
IDEXX Laboratories	$4.30B	9.65	$1.06B	$14.22	37.07

IDEXX Laboratories has a net margin of 25.03% compared to Stryker's net margin of 14.43%. IDEXX Laboratories' return on equity of 71.96% beat Stryker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	14.43%	23.63%	11.39%
IDEXX Laboratories	25.03%	71.96%	33.60%

Stryker has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market.

77.1% of Stryker shares are owned by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are owned by institutional investors. 4.6% of Stryker shares are owned by insiders. Comparatively, 0.8% of IDEXX Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

IDEXX Laboratories beats Stryker on 10 of the 16 factors compared between the two stocks.

How does IDEXX Laboratories compare to Boston Scientific?

IDEXX Laboratories (NASDAQ:IDXX) and Boston Scientific (NYSE:BSX) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, media sentiment, analyst recommendations, dividends, earnings and profitability.

IDEXX Laboratories has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market.

Boston Scientific has higher revenue and earnings than IDEXX Laboratories. Boston Scientific is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30B	9.65	$1.06B	$14.22	37.07
Boston Scientific	$20.07B	3.06	$2.90B	$2.47	17.17

In the previous week, Boston Scientific had 4 more articles in the media than IDEXX Laboratories. MarketBeat recorded 9 mentions for Boston Scientific and 5 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 0.27 beat Boston Scientific's score of 0.08 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Boston Scientific	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

IDEXX Laboratories currently has a consensus target price of $747.00, indicating a potential upside of 41.73%. Boston Scientific has a consensus target price of $67.88, indicating a potential upside of 60.09%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	0 Strong Buy rating(s)	2.70

IDEXX Laboratories has a net margin of 25.03% compared to Boston Scientific's net margin of 17.50%. IDEXX Laboratories' return on equity of 71.96% beat Boston Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Boston Scientific	17.50%	19.28%	10.89%

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.8% of IDEXX Laboratories shares are held by company insiders. Comparatively, 0.3% of Boston Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

IDEXX Laboratories beats Boston Scientific on 9 of the 16 factors compared between the two stocks.

Get IDEXX Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IDXX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IDXX vs. The Competition

Export

Metric	IDEXX Laboratories	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$40.84B	$5.42B	$7.14B	$13.26B
Dividend Yield	N/A	1.79%	2.53%	17.36%
P/E Ratio	37.07	25.77	274.34	26.20
Price / Sales	9.65	69.15	577.57	78.96
Price / Cash	34.36	32.73	27.22	34.70
Price / Book	26.22	6.04	11.23	6.40
Net Income	$1.06B	$146.97M	$3.49B	$381.07M
7 Day Performance	-1.19%	-0.38%	-1.33%	-0.30%
1 Month Performance	-1.55%	-4.20%	-5.99%	-4.53%
1 Year Performance	-16.04%	2.14%	7.27%	1.62%

IDEXX Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IDXX IDEXX Laboratories	4.6511 of 5 stars	$527.07 +1.7%	$747.00 +41.7%	-16.5%	$40.84B	$4.30B	37.07	11,000
NVST Envista	4.3689 of 5 stars	$23.77 -0.8%	$29.79 +25.3%	+12.2%	$3.85B	$2.72B	40.98	12,000
ISRG Intuitive Surgical	4.2217 of 5 stars	$414.79 +2.4%	$508.68 +22.6%	-10.1%	$143.14B	$10.06B	47.51	17,021
MDT Medtronic	4.6536 of 5 stars	$89.44 +0.9%	$103.92 +16.2%	-9.8%	$113.38B	$36.36B	22.03	95,000	Trending News Analyst Upgrade High Trading Volume
SYK Stryker	4.9463 of 5 stars	$275.57 +1.2%	$374.42 +35.9%	-23.0%	$104.47B	$25.12B	28.56	56,000	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IDXX) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IDEXX Laboratories (IDXX) Competitors

IDXX vs. NVST, ISRG, MDT, SYK, and BSX

How does IDEXX Laboratories compare to Envista?

Summary

How does IDEXX Laboratories compare to Intuitive Surgical?

Summary

How does IDEXX Laboratories compare to Medtronic?

Summary

How does IDEXX Laboratories compare to Stryker?

Summary

How does IDEXX Laboratories compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX vs. The Competition

IDEXX Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IDEXX Laboratories (IDXX) Competitors

IDXX vs. NVST, ISRG, MDT, SYK, and BSX

How does IDEXX Laboratories compare to Envista?

Which has stronger valuation and earnings, IDXX or NVST?

Do analysts prefer IDXX or NVST?

Does the media refer more to IDXX or NVST?

Which has more risk and volatility, IDXX or NVST?

Is IDXX or NVST more profitable?

Do insiders & institutionals have more ownership in IDXX or NVST?

Summary

How does IDEXX Laboratories compare to Intuitive Surgical?

Is ISRG or IDXX more profitable?

Do analysts recommend ISRG or IDXX?

Do insiders and institutionals believe in ISRG or IDXX?

Which has more risk and volatility, ISRG or IDXX?

Which has higher valuation & earnings, ISRG or IDXX?

Does the media prefer ISRG or IDXX?

Summary

How does IDEXX Laboratories compare to Medtronic?

Which has more volatility & risk, IDXX or MDT?

Does the media favor IDXX or MDT?

Do institutionals & insiders believe in IDXX or MDT?

Is IDXX or MDT more profitable?

Do analysts prefer IDXX or MDT?

Which has stronger earnings & valuation, IDXX or MDT?

Summary

How does IDEXX Laboratories compare to Stryker?

Does the media refer more to SYK or IDXX?

Do analysts rate SYK or IDXX?

Which has stronger valuation & earnings, SYK or IDXX?

Is SYK or IDXX more profitable?

Which has more volatility and risk, SYK or IDXX?

Do institutionals and insiders hold more shares of SYK or IDXX?

Summary

How does IDEXX Laboratories compare to Boston Scientific?

Which has more risk and volatility, IDXX or BSX?

Which has stronger earnings & valuation, IDXX or BSX?

Does the media favor IDXX or BSX?

Do analysts rate IDXX or BSX?

Is IDXX or BSX more profitable?

Do insiders & institutionals believe in IDXX or BSX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX vs. The Competition

IDEXX Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools